此页面上的内容需要较新版本的 Adobe Flash Player。

获取 Adobe Flash Player

Home > Media > Company News

DISHAPIAN appeared in the "Seventh people safe medication selection" list

2011-11-23

November 10, the core of the pharmaceutical industry media, "Health News" published a "safe drug investigation named the Seventh people activities" list of the latest issue of the list vote.DISHA Pharmaceutical Group produces (glipizide tablets) by virtue of "efficient, economic and security" honor list of high quality.

 

 

The "people safe use" survey, the health director by the Ministry of Health sponsored newspaper, the Ministry of Health and the full support of the Division of Pharmaceutical Affairs. Selection of activities to "health safety of drugs accompanied by" as the theme, focusing on the investigation of child medication, cancer drugs, diabetes drugs, cardiovascular drugs, anti-virus, anti-inflammatory drugs, gastrointestinal agents, gynecological medicine, orthopedic medicine and other eight community is concerned the field of medicine. "People safe medication," the survey highlights is the top companies and products are not experts in selection, but from the people a picture of the votes counted, the people are thinking is a true reflection.

 

DISHA tablets (glipizide tablets) is a DISHA Pharmaceutical Group of the "star product", is more than a decade after the inspection of hospitals and patients, has an excellent reputation in diabetes treatment, and for many years has been selected as "Shandong Famous Brand . "A national health insurance as a drug,DISHA tablets in the treatment of type Ⅱ diabetes, has a "secure, fast, economical, convenient, low incidence of hypoglycemia," characteristics.

 

This time,DISHAPIAN appeared in the "Seventh people safe medication selection" list, isDISHA Pharmaceutical Group over the years adhere to the "integrity of Mogadishu, Mogadishu pharmaceutical product integrity, production and operation of high-quality drugs forever," another sure. In 2011, the victorious DISHA Pharmaceutical Group has the "China Famous Brand", Wing House, "China Pharmaceutical Industry hundred," was awarded "China's pharmaceutical industry Most Investment Value", and took the lead through the "national new drug GMP certification." .